Shionogi & Co. Ltd.

In News

FDA Accepts Shionogi’s sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria - BioSpace

BioSpace - Jul 16, 2026

FDA Accepts sNDA to Extend Fetroja Indication to Children - Infectious Disease Special Edition

Infectious Disease Special Edition - Jul 16, 2026

Shionogi weighs future of FXS drug after double Phase III miss - Clinical Trials Arena

Clinical Trials Arena - May 14, 2026

Shionogi Selected as a “DX Stock 2026”｜塩野義製薬 - Shionogi Inc.

Shionogi Inc. - Apr 10, 2026

Jefferies Upgrades Shionogi to Buy From Hold, Adjusts Price Target to 3,800 Yen From 3,700 Yen - marketscreener.com

marketscreener.com - Jul 15, 2026

Shionogi Secures US Contract to Expand Antibiotic Manufacturing and Biothreat Preparedness - Contagion Live

Contagion Live - Apr 09, 2026

Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats - CIDRAP

CIDRAP - Apr 09, 2026

Shionogi Inc. Awarded $482 Million Contract with U.S. Government to Enhance National Preparedness for Drug-Resistant Bacterial Threats - Pharmaceutical Executive

Pharmaceutical Executive - Apr 09, 2026

F2G, Shionogi prep regulatory push after novel antifungal passes ph. 3 test - Fierce Biotech

Fierce Biotech - Jun 18, 2026

Shionogi secures $482m BARDA contract to tackle AMR crisis - Pharmaceutical Technology

Pharmaceutical Technology - Apr 09, 2026

Shionogi nabs initial $119M award from BARDA to establish US antibiotic plant - Fierce Pharma

Fierce Pharma - Apr 08, 2026

Shionogi ranks second in 2026 Antimicrobial Resistance Benchmark report - European Pharmaceutical Review

European Pharmaceutical Review - May 19, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment